Dare Bioscience (DARE) vs Marker Therapeutics (MRKR)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
Marker Therapeutics (MRKR) has outperformed Dare Bioscience (DARE) over the past year, losing 1.9% versus a loss of 64.8%. Over five years, MRKR leads with a -93.5% price change compared with -95.8% for DARE. Marker Therapeutics is the larger company by market cap ($15.8 million vs $15.2 million), about 1.0 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | DARE | MRKR |
|---|---|---|
| Share price | $0.7722 | $0.95 |
| Market cap | $15.19M | $15.84M |
| 1-day change | -2.25% | -8.65% |
| YTD return | -59.07% | -30.20% |
| 1-year return | -64.81% | -1.89% |
| 5-year return | -95.81% | -93.46% |
| EPS (TTM) | $-0.71 | $-0.42 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $3.78 | $2.46 |
| 52-week low | $0.69 | $0.84 |
| Distance from 52-week high | -79.57% | -61.38% |
| Average volume | 524.37K | 64.80K |
| Shares outstanding | 19.67M | 16.67M |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- MRKR has outperformed DARE by 62.9 percentage points over the past year.
DARE vs MRKR FAQ
Which is bigger, Dare Bioscience or Marker Therapeutics?
Marker Therapeutics (MRKR) is larger, with a market capitalization of $15.84M compared with $15.19M for Dare Bioscience (DARE).
Which stock has performed better over the past year, DARE or MRKR?
MRKR returned -1.89% over the past 12 months, compared with -64.81% for DARE (price return, excluding dividends). Past performance does not predict future results.
Are Dare Bioscience and Marker Therapeutics in the same industry?
Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.